(Hypertension. 2002;39:581.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
From the Department of Physiology and Biophysics, University of Mississippi Medical Center (J.C., L.W.H., R.L.H.), Jackson, Miss.
Correspondence to Dr Robert L. Hester, Department of Physiology and Biophysics, University of Mississippi Medical Center, 2500 North State Street, Jackson, Mississippi 39216-4505. E-mail rhester{at}physiology.umsmed.edu
| Abstract |
|---|
|
|
|---|
Key Words: microcirculation prostacyclin veins endothelium
| Introduction |
|---|
|
|
|---|
Vasodilators released from the endothelium include the arachidonic acid metabolite prostacyclin, nitric oxide, and endothelium-derived hyperpolarizing factor. However, the quantitative role of these vasodilators in different regions of the vasculature has not been characterized. Nitric oxide appears to have a minimal role in regulating arteriolar diameter during an increase in metabolic rate.35 Previous studies from our laboratory have shown that arachidonic acid metabolites make a major contribution to the regulation of arteriolar diameter during muscle stimulation.6,7
Arachidonic acid is released from membrane phospholipids through the direct action of phospholipase A2 (PLA2). Further metabolism of arachidonic acid generates three main groups of eicosanoids: prostaglandins and thromboxanes by cyclooxygenase; leukotrienes and lipoxins by lipoxygenase; and epoxides by cytochrome P-450 epoxygenase. Prostacyclin (prostaglandin I2) is a very powerful vasodilator that is produced primarily in vascular endothelial cells.8 There are both secretory and intracellular forms of PLA2.9 The cytosolic form of PLA2 includes both Ca2+-dependent and Ca2+-independent isozymes. However, it is not yet certain which of these enzymes is responsible for the release of arachidonic acid for the regulation of arteriolar diameter during muscle stimulation.
Ellsworth et al have suggested a role for ATP released from red blood cells during hypoxia.10,11 Application of ATP at a physiological concentration to the lumen of arterioles and venules in vivo induces increases in blood flow and tissue PO2.10 A recent in vivo study from our laboratory has demonstrated that administration of ATP in venules will result in a vasodilation of the adjacent arteriole.12 The present study was designed to determine the cellular processes involved in prostacyclin release from venular endothelial cells in response to increases in ATP. We tested the hypothesis that an ATP-induced increase in intracellular Ca2+ in the venous endothelium was necessary to stimulate prostacyclin synthesis.
| Methods |
|---|
|
|
|---|
using an enzyme-immunoassay kit from Neogen Corp.
Protocols for In Vitro Perfusion Studies
Isolated veins were perfused with MOPS-PSS for a 50-minute equilibration period. The bath was then replaced with fresh MOPS-PSS every 10 minutes, with the entire 1 mL bath solution being collected for measurement of prostacyclin release. The protocols involved a 10-minute perfusion of the vessel with MOPS-PSS containing 100 µmol/L ATP. The perfusate was changed to include either a Ca2+ free solution or a variety of inhibitors before a second 10-minute perfusion with MOPS-PSS containing 100 µmol/L ATP. For the Ca2+ dependence studies, there was a 10-minute wash period between the two ATP perfusion periods. For the PLA2 inhibitor studies, there was a 20-minute wash period between the two ATP perfusion periods. The concentration of 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetra(acetoxy-methyl) ester (BAPTA/AM) used to chelate intracellular calcium was chosen on the basis of previous studies13,14 and our Ca2+ studies in human umbilical vein endothelial cells (HUVEC). The concentrations of the phospholipase A2 inhibitors, AACOCF3 and bromoenol lactone (BEL), were chosen on the basis of previously published studies.15
Culture of Human Umbilical Vein Endothelial Cells
Primary cultures of HUVEC were purchased from Clonetics (Walkersville, Md) and further propagated according to the manufacturers directions. The cells were examined for positive immunofluorescence staining of von Willebrand factor (vWF) and for uptake of acetylated low density lipoprotein labeled with 1,1-dioctadecyl-3,3,3,3-tetramethylindocarbocyanine perchlorate (DiI-Ac-LDL, Molecular Probes), which are characteristic features of endothelial cells. As preliminary studies showed negative staining of the cells (<90%) after 4 to 5 passages in cell culture, cells after only 2 to 3 passages were used throughout these experiments.
Measurement of Intracellular Free Ca2+ Concentration
Changes in intracellular free Ca2+ concentration [Ca2+]i in HUVEC were assessed using the fluorescent Ca2+ indicator fura2 (Molecular Probes). Cells were plated onto glass coverslips at a density of 5x104 cells/cm2 and incubated overnight. To load the Ca2+ indicator, the cells were washed with extracellular solution containing (in mmol/L): 125 NaCl, 6 KCl, 1.5 CaCl2, 1 MgCl2, 10 HEPES, 10 glucose. The cells were loaded for 30 minutes at 37°C with fura2-AM diluted to a final concentration of 2 µmol/L in the extracellular solution. The coverslip with fura2-loaded cells was washed with extracellular solution and positioned diagonally in a quartz cuvette maintained at 37°C. The fura2-loaded cells were excited alternately at 340 nm and 380 nm and the emitted fluorescence was measured at 510 nm using a Photon Technology International RatioMaster RC-D spectrofluorometer. The [Ca2+]i was estimated using the equation previously described.16
Prostacyclin Release from HUVEC Cultures
Cultured HUVEC were plated on 24-well tissue culture plates at a density of 105 cells/cm2, incubated overnight in EGM BulletKit medium (Clonetics), and serum starved for 16 hours. The cells were washed twice with PSS before stimulation with the appropriate agent in 300 µL MOPS-PSS. The tissue culture supernatant (200 µL) was collected after stimulation to determine prostacyclin synthesis.
Data Analysis
For statistical analysis of data from the vessel perfusion studies, the prostacyclin response to the second application of ATP was calculated as a percentage of the release following the first application of ATP. The responses to the treatments were compared with the control responses using the Mann-Whitney rank-sum test to determine statistical significance.
Chemicals
Arachidonyl trifluoromethyl ketone (AACOCF3), BEL, and BAPTA/AM, were purchased from Calbiochem, Cayman Chemical Company, and Molecular Probes, Inc, respectively. Concentrated (104-fold) stock solutions were prepared in dimethyl sulfoxide (DMSO) and frozen at -80°C. Reagents for cell culture were purchased from Clonetics. All other reagents were obtained from Sigma.
| Results |
|---|
|
|
|---|
ATP) or the perfusion solution alone (
ATP) significantly inhibited prostacyclin synthesis during the second ATP stimulus (Figure 1B, P<0.01), indicating that ATP-induced Ca2+ influx is essential for prostacyclin synthesis. Chelation of intracellular Ca2+, by perfusion of 10 µmol/L BAPTA/AM for 10 minutes, also significantly inhibited ATP-induced prostacyclin synthesis (Figure 1D, P<0.01), demonstrating the importance of intracellular Ca2+ in ATP-induced prostacyclin synthesis.
|
Role of Cytosolic PLA2 in ATP-Induced Prostacyclin Synthesis
We determined if the Ca2+-dependent process in ATP-induced prostacyclin synthesis was mediated by cytosolic PLA2. To ensure that the veins had recovered more completely from the first ATP stimulation, the washing period was extended to 20 minutes (Figure 2A); under these conditions the second response averaged 87±13% (n=6) of the initial response. Treatment of the vessels with the Ca2+-dependent cytosolic PLA2 inhibitor AACOCF3 (30 µmol/L) abolished ATP-induced prostacyclin synthesis (Figure 2B, P<0.01). The Ca2+-independent PLA2 inhibitor BEL (10 µmol/L) also significantly inhibited this response (Figure 2C, P<0.01). These results suggest that both Ca2+-dependent and Ca2+-independent PLA2 contribute to ATP-induced prostacyclin synthesis in the venous endothelium.
|
ATP-Induced Changes in [Ca2+]i and Prostacyclin Synthesis in HUVEC
The preceding observations suggest that an ATP-induced increase in [Ca2+]i in venous endothelial cells was likely to be responsible for the stimulation of prostacyclin synthesis. To verify our hypothesis, we initially aimed to measure ATP-induced [Ca2+]i changes in endothelial cells isolated from small veins from the hamster. Due to technical difficulties culturing these cells, changes in [Ca2+]i were measured in HUVECs instead. As shown in Figure 3A, ATP induced a sustained increase in [Ca2+]i in HUVECs. The transient Ca2+ peak arose within seconds of ATP stimulation. Removal of extracellular Ca2+ abolished the sustained increase in [Ca2+]i induced by ATP (Figure 3C). Chelation of intracellular Ca2+ with 10 µmol/L BAPTA (10 minutes loading) abolished both the transient peak and the sustained increase in [Ca2+]i (Figure 3D). Stimulation of HUVECs with ATP increased prostacyclin synthesis (Figure 4A). Furthermore, the ATP-induced prostacyclin synthesis reached a peak level 2 minutes after application of 10 µmol/L ATP (Figure 4B).
|
|
| Discussion |
|---|
|
|
|---|
Stimulation of cells with ATP induces an increase in [Ca2+]i by both activation of Ca2+ release from intracellular Ca2+ stores and Ca2+ influx through ion channels in the plasma membrane.20,21 Removal of extracellular Ca2+ prevents the Ca2+ influx that is essential for maintaining a sustained increase in [Ca2+]i; such removal was found to abolish ATP-induced prostacyclin synthesis in these vessels. This finding is consistent with previous observations in cell culture systems.2224 Treatment of the vessel with the Ca2+-dependent cytosolic PLA2 inhibitor AACOCF3 also inhibited prostacyclin synthesis, implicating the cytosolic PLA2 as the Ca2+-dependent process in ATP-induced prostacyclin synthesis. An increase in [Ca2+]i is required for translocation of the Ca2+-sensitive cytosolic PLA2 from the cytosol to the endoplasmic reticulum and the nuclear membrane. Furthermore, it has been suggested that a sustained elevation of intracellular Ca2+ and phosphorylation of PLA2 by mitogen-activated protein kinase are important for full activation of this PLA2.24,25 Several isotypes of PLA2 have been characterized and their role in generating arachidonic acid in specific cell types still needs further investigation. We also found that the Ca2+-independent PLA2 inhibitor BEL substantially inhibited ATP-induced prostacyclin synthesis in the venous endothelium. Because our data show a similar pattern with the Ca2+-dependent PLA2 inhibitor, we speculate that Ca2+-dependent and Ca2+-independent isozymes of PLA2 play a synergistic role in ATP-induced prostacyclin synthesis.
The in vivo studies that we have performed previously have examined the role of arachidonic acid metabolites released from
100 µm venules in the dilation of arterioles during muscle stimulation.6,7,12 The ideal approach to investigating the contribution of ATP to functional hyperemia in hamster cremaster vessels would be to conduct studies on isolated venules from the hamster cremaster muscle. We thus conducted preliminary studies on such venules. Those studies revealed an increase in prostacyclin synthesis in response to ATP, as in our present study with the larger veins. However, the basal level of prostacyclin synthesis was below the detection limit of the assay, thus limiting our ability to detect changes in prostacyclin synthesis. Because such micro-vessels are very difficult to isolate and perfuse, the present study characterized ATP-induced prostacyclin synthesis in a relatively large vein. Although this may limit generalization from our data, these data provide direct evidence that venous endothelium can release the vasoactive substance prostacyclin. Moreover, higher concentrations of prostacyclin might be attained in the smaller venules owing to their greater surface area to volume ratio. Additionally, we have not been able to isolate endothelial cells from small veins or venules. Therefore we used HUVECs to examine the intracellular Ca2+ changes during ATP treatment. The measurements of prostacyclin synthesis in cultured HUVECs (Figure 4) corroborate the data from the isolated veins presented in Figures 1 and 2. The cytosolic concentration of ATP in erythrocytes is in the range 4 to 5 mmol/L. Previous studies have reported that released ATP can reach a concentration in the range 0.2 to 20 µmol/L under various experimental conditions.26 Higher concentrations may be attained locally. Moreover, previous studies from our laboratory have demonstrated that venular application of both 1 µmol/L and 100 µmol/L ATP induced arteriolar dilation.12 We used 100 µmol/L ATP in the present study, rather than 1 µmol/L ATP, to better characterize the effect of the inhibitors.
The experiments presented in this paper are a continuation of our studies determining the role of the release of arachidonic acid metabolites from venular endothelium in the control of arteriolar diameter. We have presented evidence that, in vivo, the venular endothelium does release products of the cyclooxygenase pathway, presumably prostacyclin. The stimuli for the release of prostacyclin are not known. On the arteriolar side of the circulation, several metabolic factors, including increased PCO2, decreased PO2, and acidosis, have been shown to stimulate prostanoid release.2729 Recent studies have indicated that erythrocytes release ATP under conditions of hypoxia.10 Such release should occur predominantly in the venules where PO2 levels decline as a result of muscle stimulation. Future studies will be needed to determine the overall quantitative importance of ATP release from erythrocytes in the stimulation of prostanoid release from the venular endothelium.
In conclusion, our study shows that ATP induces significant production of prostacyclin by the venous endothelium. A Ca2+-dependent cytosolic PLA2 signaling pathway is essential to this process. These data provide more evidence that release of ATP from erythrocytes may be important in the regulation of arteriolar diameter in the microcirculation.
| Acknowledgments |
|---|
Received September 22, 2001; first decision November 7, 2001; accepted November 21, 2001.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
L. W. Hammer, C. R. Overstreet, J. Choi, and R. L. Hester ATP stimulates the release of prostacyclin from perfused veins isolated from the hamster hindlimb Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R193 - R199. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |